Slide Insurance director sells 7,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. (SLDE) director Stephen L. Rohde reported on September 14, 2026 exercising stock options for 7,500 shares of common stock at an exercise price of $1.38 per share, then selling 7,500 shares of common stock at $26.40 per share the same day. After the exercise, he held 35,000 stock options directly, which are described as fully vested and exercisable, with the option series expiring on July 12, 2033. No Rule 10b5-1 trading plan is reported for these transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1 | 7,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,500 | $1.38 | $10K |
| Sale | Common Stock | 7,500 | $26.40 | $198K |
Footnotes (1)
- F1. These stock options are fully vested and exercisable.
Key Figures
Key Terms
stock options financial
fully vested financial
derivative security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did SLDE director Stephen L. Rohde report?
Did the SLDE director retain any options after the September 14, 2026 transactions?
Were the Slide Insurance Holdings (SLDE) transactions under a Rule 10b5-1 plan?
What type of securities did the SLDE director trade in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.